Prime Medicine (PRME) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

4.240
-0.150-3.42%

Close Aug 16 16:00 ET

4.270
+0.030+0.71%

Post 20:02 ET

508.93MMarket Cap-1953P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Analysts Offer Insights on Healthcare Companies: Guardant Health (GH) and Prime Medicine, Inc. (PRME)
TipRanksAug 13 08:33 ET · Ratings
Express News | HC Wainwright & Co. Reiterates Buy on Prime Medicine, Maintains $10 Price Target
BenzingaAug 9 06:02 ET
Prime Medicine Analyst Ratings
BenzingaAug 9 06:01 ET · Ratings
Express News | Prime Medicine Inc : JP Morgan Cuts Target Price to $14 From $15
ReutersAug 9 02:19 ET
Buy Rating for Prime Medicine, Inc. on Strong Pipeline and Financial Health
TipRanksAug 9 02:15 ET · Ratings
Buy Rating Affirmed for Prime Medicine, Inc. on Strong Clinical Trials and Financial Footing
TipRanksAug 8 16:16 ET · Ratings

Comments

Hudsy

May 29 08:07

Googly Eyes

$Prime Medicine (PRME.US)$ Why is it everytime googly eyes purchases stock, it goes to chit? Anyone?

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...

Jaguar8

Apr 29 06:02

$Prime Medicine (PRME.US)$
NEWS
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

MARKET-TEST-DUMMY

Feb 17 12:33

$Prime Medicine (PRME.US)$ possible gains , just don't thinknit will hit the 10.50 mark, but it might

Moomoo AI

Jan 5 07:08

CEO Dr. Gottesdiener anticipates that Dr. Reine's extensive experience will significantly contribute to Prime Medicine's financing strategies and operational efficiency. Dr. Reine is enthusiastic about joining the company as it transitions to a clinical-stage venture.

Press Release: Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

PRME Prime Medicine

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target